The DOI matches its Crossref record; 160 of the 175 references it cites were found in a registry or an index.
p21 in Cancer Research
Open accessAbstract
p21 functions as a cell cycle inhibitor and anti-proliferative effector in normal cells, and is dysregulated in some cancers. Earlier observations on p21 knockout models emphasized the role of this protein in cell cycle arrest under the p53 transcription factor activity. Although tumor-suppressor function of p21 is the most studied aspect of this protein in cancer, the role of p21 in phenotypic plasticity and its oncogenic/anti-apoptotic function, depending on p21 subcellular localization and p53 status, have been under scrutiny recently. Basic science and translational studies use precision gene editing to manipulate p21 itself, and proteins that interact with it; these studies have led to regulatory/functional/drug sensitivity discoveries as well as therapeutic approaches in cancer field. In this review, we will focus on targeting p21 in cancer research and its potential in providing novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, 38-50% of human cancers carry inactivating alterations in TP53 (ref. 132 ) , 48-80% in CDKN2A 133 and 14% in CIP1 (ref. 134 ) , while 15-20% and up to 8% harbour oncogenic mutations in RAS and BRAF , respectively 135,136 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [134]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells
He, Y., & Yu, B. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4204 · Cited by 29
RetractedGenome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,712
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells
Ikeda, R., Che, X., Yamaguchi, T., Ushiyama, M., Zheng, C., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K. T., Jeung, H., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00057.x · Cited by 2,268
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Cited by
Sorted by citations
Items 101–200 of 337
Sun, Y., Wang, X., Fu, G., & Geng, X. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.009 · Cited by 16
RetractedUbiquitination of p21 by E3 Ligase TRIM21 Promotes the Proliferation of Human Neuroblastoma Cells
Wang, F., Wu, Z., Li, Q., Ni, Z., Wang, C., & Lu, J. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08661-3 · Cited by 16
Guan, J., Guan, B., Shang, H.-X., Peng, J., Yang, H. Y., & Lin, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113630 · Cited by 16
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaPreprint
Fluck, M. F. Z., Massó-Vallés, D., Giuntini, F., González-Larreategui, Í., Kaur, J., Casacuberta‐Serra, S., Jauset, T., Martínez-Martín, S., Martín-Fernández, G., del Pozo, E. S., et al. (2023) · Genes & Development · doi:10.1101/gad.350078.122 · Cited by 16
Li, M., Wang, L., Li, S., Hua, C., Gao, H., Ning, D., Li, C., Zhang, C., & Jiang, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314790 · Cited by 15
Le, T. T., Nguyen, P. H., Nguyen, V. P., & Nguyen, T. N. (2023) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.378600 · Cited by 15
Chang, S., Ren, D., Zhang, L., Liu, S., Yang, W., Cheng, H., Zhang, X., Hong, E., Geng, D., Wang, Y., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217120 · Cited by 15
Vilková, M., Michalková, R., Kello, M., Sabolová, D., Takáč, P., Kudlicková, Z., Garberová, M., Tvrdoňová, M., Béreš, T., & Mojžíš, J. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02911-0 · Cited by 15
Novel thiazolidine derivatives as potent selective pro-apoptotic agents
Hafez, D. E., Hafez, E., Eddiasty, I., Shih, S., Chien, L.-C., Hong, Y.-J., Lin, H., Keeton, A. B., Piazza, G. A., Abdel‐Halim, M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105143 · Cited by 14
Ma, Z., Zuo, Y., & Wang, W. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac072 · Cited by 14
Anaya‐Eugenio, G. D., Carcache, P. J. B., Ninh, T. N., Ren, Y., Soejarto, D. D., & Kinghorn, A. D. (2020) · Phytotherapy Research · doi:10.1002/ptr.6930 · Cited by 14
The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer
Russi, M., Marson, D., Fermeglia, A., Aulić, S., Fermeglia, M., Laurini, E., & Pricl, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108009 · Cited by 14
Zhao, M., Liu, W., Zhang, X., Zhang, Y., & Luo, B. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28338 · Cited by 14
Therapeutic potential of marine peptides in malignant melanoma
Ahmed, S., Alam, W., Alsharif, K. F., Aschner, M., Alzahrani, F. M., Saso, L., & Khan, H. Z. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115771 · Cited by 15
Small interfering RNA‑mediated knockdown of KRT80 suppresses colorectal cancer proliferation
Lin, J., Fan, X., Chen, J., Xie, X., & Yu, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9306 · Cited by 14
p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model
Zhang, Q., Guo, Y., Kang, M., Lin, W.-H., Wu, J.-C., Yu, Y., Li, L., & Sang, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282063 · Cited by 13
Xu, X.-L., Lan, J., Huang, H., Dai, W., Peng, X., Liu, S., Chen, W., Huang, L.-J., Liu, J., Li, X.-J., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117234 · Cited by 13
MCM4 acts as a biomarker for LUAD prognosis
Tan, Y., Ding, L., & Li, G. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17819 · Cited by 13
Vitamin D and Its Receptors in Cervical Cancer
Dong, H., Chen, S., Liang, X., Cai, Q., Zhang, X., Xie, J., & Sun, Z. (2024) · Journal of Cancer · doi:10.7150/jca.87499 · Cited by 16
The Emerging Role of p21 in Diabetes and Related Metabolic Disorders
ElMitwalli, O. S., Darwish, R., Al-Jabery, L., Algahiny, A. T., Roy, S., Butler, A. E., & Hasan, A. S. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313209 · Cited by 17
Signaling pathways in glioblastoma
Gomes, I., Oliveira, R. J. D. S., & Girol, A. P. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104647 · Cited by 13
Schuller, S., Sieker, J., Riemenschneider, P., Köhler, B., Drucker, E., Weiler, S. M. E., Dauch, D., Sticht, C., Goeppert, B. F., Roessler, S. K., et al. (2022) · Cancers · doi:10.3390/cancers14020459 · Cited by 13
UTP18-mediated p21 mRNA instability drives adenoma-carcinoma progression in colorectal cancer
Pan, M., Xiao, T., Xu, L., Xie, Y., & Ge, W. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112423 · Cited by 14
Anaya‐Eugenio, G. D., Tan, C. Y., Harinantenaina, L., & de Blanco, E. J. C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110124 · Cited by 16
Hashem, M. S., Fahim, A. M., & Elsayed, G. H. (2025) · RSC Advances · doi:10.1039/d5ra08332j · Cited by 12
Conjugated linoleic acid strengthens the apoptotic effect of cisplatin in A549 cells
Yüce, M., Gümüşkaptan, Ç., Çon, A. H., & Yazıcı, F. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106731 · Cited by 12
Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer
Zafeiropoulou, K., Kalampounias, G., Alexis, S., Anastasopoulos, D., Symeonidis, A. S., & Katsoris, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0289904 · Cited by 12
Myeza, N., Slabber, C., Munro, O. Q., Sookai, S., Zacharias, S. C., Martins-Furness, C., & Harmse, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176764 · Cited by 12
The Role of Chronic Inflammation in Pediatric Cancer
Mella, C., Tsarouhas, P., Brockwell, M., & Ball, H. C. (2025) · Cancers · doi:10.3390/cancers17010154 · Cited by 13
Rahimifard, M., Bagheri, Z., Hadjighassem, M., Jaktaji, R. P., Behroodi, E., Haghi‐Aminjan, H., Movahed, M. A., Latifi, H., Hosseindoost, S., Zarghi, A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120505 · Cited by 12
LINC00324 in cancer: Regulatory and therapeutic implications
Xia, Q., Shen, J., Wang, Q., Ke, Y., Yan, Q., Li, H., Zhang, D., & Duan, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1039366 · Cited by 12
Lo, H.-C., Hua, W.-J., Yeh, H. H., Lin, Z., Huang, L.-C., Ciou, Y., Ruan, R., Lin, K.-F., Tseng, A.-J., Wu, A. T. H., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122255 · Cited by 11
RNA-Independent Regulatory Functions of lncRNA in Complex Disease
Kafida, M., Karela, M., & Giakountis, A. (2024) · Cancers · doi:10.3390/cancers16152728 · Cited by 11
Kot, M., Simiczyjew, A., Wądzyńska, J., Ziętek, M., Matkowski, R., & Nowak, D. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01788-3 · Cited by 13
Monk, J. M., Liddle, D. M., Hutchinson, A. L., Burns, J. L., Wellings, H. R., Cartwright, N. M., Muller, W. J., Power, K. A., Robinson, L. E., & David, W. L. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108763 · Cited by 11
NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death
Kiss, A., Csikos, C., Regdon, Z., Polgár, Z., Virág, L., & Hegedűs, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168869 · Cited by 11
Saleh, S. A. K., Adly, H. M., AlJahdali, I. A., & Khafagy, A. A. (2022) · Biomolecules · doi:10.3390/biom12020260 · Cited by 11
LSD1 downregulates p21 expression in vascular smooth muscle cells and promotes neointima formation
Yuan, B., Liu, H., Pan, X., Dong, X., Qu, L., Sun, J. T., & Pan, L. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114947 · Cited by 11
Liu, Z., Hurst, D. R., Qu, X., Lu, L.-G., Wu, C., Li, Y., & Li, Y. (2020) · Military Medical Research · doi:10.1186/s40779-020-00275-3 · Cited by 11
Kozlova, N. I., Morozevich, G. E., Геворкян, Н. М., & Berman, A. E. (2020) · Aging · doi:10.18632/aging.202243 · Cited by 11
Deciphering molecular pathways in urological cancers: A gateway to precision therapeutics
Hushmandi, K., Farahani, N., Einollahi, B., Salimimoghadam, S., Alimohammadi, M., Liang, L., Liu, L., & Sethi, G. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.06.009 · Cited by 11
The role of p53/p21/p16 in DNA damage signaling and DNA repair
Kulaberoglu, Y., Hergovich, A., & Gómez, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00015-5 · Cited by 11
Ryczkowska, M., Maciejewska, N., Olszewski, M., Witkowska, M., & Makowiec, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13867-x · Cited by 10
Nedara, K., Reinhardt, C., Lebraud, E., Arena, G., Gracia, C., Buard, V., Pioche‐Durieu, C., Castelli, F. A., Colsch, B., Bénit, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958155 · Cited by 10
Mohajerani, F., Tehrankhah, Z. M., Rahmani, S., Afsordeh, N., Shafiee, S., Pourgholami, M. H., Soltani, B. M., & Sadeghizadeh, M. (2024) · BMC Cancer · doi:10.1186/s12885-023-11755-9 · Cited by 9
Marine peptides in lymphoma: surgery at molecular level for therapeutic understanding
Ahmed, S., Aschner, M., Alsharif, K. F., Allahyani, M. A., Huang, G., Wan, C. C., & Khan, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03901-w · Cited by 9
Chen, Y., Li, L., Zhang, R., & Liu, F. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148743 · Cited by 10
Surya, R., Surya, E., Nugroho, D., Romulo, A., Kamal, N., Rahayu, W. P., Benchawattananon, R., & Oh, J.-S. (2023) · Journal of Ethnic Foods · doi:10.1186/s42779-023-00176-5 · Cited by 9
Zhao, H., Bi, F., Li, M., Diao, Y., & Zhang, C. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110961 · Cited by 9
Cappadone, C., Malucelli, E., Zini, M., Farruggia, G., Picone, G., Gianoncelli, A., Notargiacomo, A., Fratini, M., Pignatti, C., Iotti, S., et al. (2021) · Nutrients · doi:10.3390/nu13041376 · Cited by 9
Santarelli, R., Pompili, C., Montani, M. S. G., Romeo, M. A., Gonnella, R., D’Orazi, G., & Cirone, M. (2021) · IUBMB Life · doi:10.1002/iub.2503 · Cited by 9
A Boolean Model of the Proliferative Role of the lncRNA XIST in Non-Small Cell Lung Cancer Cells
Gupta, S., Silveira, D. A., Hashimoto, R. F., & Mombach, J. C. M. (2022) · Biology · doi:10.3390/biology11040480 · Cited by 9
Lee, T.-Y., Tseng, C.-J., Wang, J.-W., Wu, C.-P., Chung, C.-Y., Tseng, T., & Lee, S.-C. (2023) · Biomedicines · doi:10.3390/biomedicines11041136 · Cited by 10
miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53
Jie, X.-F., Li, Y., Liu, S., Fu, Y., & Xiong, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.057 · Cited by 8
Patel, H. A., Wang, J., Zinn, C. J., Learmonth, M., Bian, X., Jurk, D., Lerman, L. O., Wolfram, J., & Hickson, L. J. (2026) · Kidney International · doi:10.1016/j.kint.2025.10.019 · Cited by 8
Zhang, X., Hu, F., Zhu, B., Jiao, X., Li, Y., Wu, S., Ren, G., Li, J., Xie, Q., Pan, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02490-9 · Cited by 8
ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma
Li, Q., Hou, J., Guo, C., Zhang, Y., Liu, L., Hu, H., Shi, S., Ji, Y., Guo, L., Shi, Y., et al. (2021) · BioMed Research International · doi:10.1155/2021/8305299 · Cited by 8
RetractedFemtosecond-laser stimulation induces senescence of tumor cells in vitro and in vivo
Zhao, X., Tang, W., Wang, H., & He, H. (2021) · Biomedical Optics Express · doi:10.1364/boe.449456 · Cited by 7
Negreti, A. A., Ferreira‐Silva, G. Á., Pressete, C. G., Fonseca, R., Candido, C. C., Graminha, A. E., Doriguetto, A. C., Caixeta, E. S., Hanemann, J. A. C., Castro‐Gamero, A. M., et al. (2022) · New Journal of Chemistry · doi:10.1039/d1nj04291b · Cited by 8
Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer
Kim, M. J., Kim, D., Koo, J. S., Lee, J. H., & Nam, K. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221089933 · Cited by 8
Liu, C., Wu, C.-L., Yeh, I., Wu, S., Sze, C., & Gean, P. (2021) · PubMed Central · Cited by 8
Tripathi, P., Soni, R., Antra, & Tandon, V. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.015 · Cited by 8
Sun, D., Miao, Y., Xu, W., Shi, W., Wang, L., Chen, T., Wen, H., Wu, H., & Liu, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03978 · Cited by 8
Pathirana, O. C., Paranagama, M. P., Wijesundera, K. K., Mahakapuge, T. A. N., Abeykoon, A. U., & Rajapakse, J. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04712-x · Cited by 7
Brochado, A. C. B., de Moraes, J. A., de Oliveira, B. R., Lima, V. H. D. S., Mariano, E. D., Karande, S., Romasco, T., Leite, P. E. C., Mourão, C. F., & Alves, G. G. (2024) · Cancers · doi:10.3390/cancers16234003 · Cited by 8
Yi, X., Xiao, Z., Chen, J., Chen, G., & Ma, P. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s547924 · Cited by 7
Betulinic acid and apoptosis-involved pathways: Unveiling its bidirectional regulatory role
Gao, Y., Wang, D., Zheng, Y., & Sun, H. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178361 · Cited by 7
Gao, P., Zhao, K., Lu, W., Wang, L., & Zhang, P. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02231-8 · Cited by 7
Damane, B. P., Mulaudzi, T. V., Kader, S., Naidoo, P., Savkovic, S. D., Dlamini, Z., & Mkhize‐Kwitshana, Z. L. (2023) · Cancers · doi:10.3390/cancers15030748 · Cited by 7
Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide
Cui, J., Wang, Y., Li, X., Xiao, F., Ren, H., & Wu, M. Y. (2023) · Molecules · doi:10.3390/molecules28093912 · Cited by 7
Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent
Son, K. H., Lee, D. S., Park, G., Jeon, S. Y., Lee, J.-E., Jeon, H.-J., Lee, S., Park, W.-J., Shin, Y., Kim, S., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c05971 · Cited by 7
Rahnama, S., Tehrankhah, Z. M., Mohajerani, F., Mohammadi, F. S., Yeganeh, Z. Y., Najafi, F., Babashah, S., & Sadeghizadeh, M. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04168-5 · Cited by 7
Malinowska, K., Tarhonska, K., Foksiński, M., Sicińska, P., Jabłońska, E., Reszka, E., Zarakowska, E., Gackowski, D., Górecka, K. M., Balcerczyk, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312786 · Cited by 7
Thimoteo, R. R. C., Costa, D. S. S., Martino, T., Barcellos, J. C. F., Coelho, M. G. P., Costa, P. R. R., Sabino, K. C. C., Simão, T. D. A., Dias, A. G., & Justo, G. A. (2021) · Anticancer Research · doi:10.21873/anticanres.15306 · Cited by 7
Functional interplay within the epitranscriptome: Reality or fiction?
Worpenberg, L., Paolantoni, C., & Roignant, J. (2021) · BioEssays · doi:10.1002/bies.202100174 · Cited by 7
Geng, Q., Zhao, H., Zhou, Z., Chen, X., Zhao, H., Chen, N., Li, Y., Guo, C., Yang, A., Beer, D. G., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121560 · Cited by 8
Deng, Q., Li, C., Liu, J., Ji, X., Wan, X., Wang, C., Sun, H., Fang, Q., Gu, W.-Q., Ma, C., et al. (2023) · PubMed Central · Cited by 7
Deng, M., Tan, J., Fan, Z., Pham, L. V., Zhu, F., Fang, X., Zhao, H., Young, K., & Xu, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-45721-z · Cited by 7
Bundy, J., Shaw, J., Hammel, M., Nguyen, J. M., Robbins, C., Mercier, I., & Suryanarayanan, A. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2340912 · Cited by 7
Mutational landscape of TP53 and CDH1 in gastric cancer
Cai, H.-Q., Zhang, L., Fu, L.-M., Xu, B., & Jiao, Y. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i2.276 · Cited by 9
Magalhães, M., Domínguez-Martín, E. M., Jorge, J., Gonçalves, A. C., Massenzio, F., Spigarelli, R., Ribeiro‐Rodrigues, T., Catarino, S., Girão, H., Monti, B., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118689 · Cited by 6
Peripubertal Nutritional Prevention of Cancer-Associated Gene Expression and Phenotypes
Brane, A. C., Arora, I., & Tollefsbol, T. O. (2023) · Cancers · doi:10.3390/cancers15030674 · Cited by 6
Thabet, N. M., Abdel-Rafei, M. K., Askar, M. A., Ibrahim, S. A., Ahmed, O. M., & Elbakry, M. M. M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104161 · Cited by 6
Egusquiza-Alvarez, C. A., Moreno-Londoño, Á. P., Alvarado-Ortiz, E., Ramos‐Godínez, M. D. P., Sarabia-Sánchez, M. Á., Castañeda‐Patlán, M. C., & Robles‐Flores, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052712 · Cited by 6
Laha, S., Das, S., Banerjee, U., Ganguly, T., Senapati, S., Chatterjee, G., & Chatterjee, R. (2024) · Gene · doi:10.1016/j.gene.2024.148903 · Cited by 6
Jia, X., Zhao, Y., Li, Q., Lu, X., Wang, X., Wang, H., Shi, Z., Xu, Y., Huang, B., Huang, F., et al. (2024) · Journal of Breast Cancer · doi:10.4048/jbc.2024.0063 · Cited by 6
Correlation between HPV PCNA, p16, and p21 Expression in Lung Cancer Patients
Marcos, B. D. F. S., de Oliveira, T. H. A., do Amaral, C. M. M., Muniz, M. T. C., & de Freitas, A. C. (2022) · Cellular Microbiology · doi:10.1155/2022/9144334 · Cited by 6
Long non-coding RNAs - SNHG6 emerge as potential marker in colorectal cancer
Jurkiewicz, M., Szczepaniak, A., & Zielińska, M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189056 · Cited by 6
CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription
Ye, X., Liu, X., Gao, M., Gong, L., Tian, F., Shen, Y., Hu, H., Sun, G., Zou, Y., & Gong, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638802 · Cited by 6
Zhao, L., Punga, T., & Sanyal, S. (2025) · eLife · doi:10.7554/elife.106469 · Cited by 6
Kang, M., Lee, Y., Lee, Y., Kim, E., Jo, J., Shin, H., Choi, J., Oh, J., Yoon, H., & Kang, H. W. (2024) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2024.112990 · Cited by 5
Casso-Chapa, B., González, N. A. V., Le, N., Palaskas, N. L., Nead, K. T., Eutsey, L. P., Samanthapudi, V. S. K., Osborn, A. M., Lee, J., Mejia, G. F., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319870 · Cited by 5
p21 Promoter Methylation Is Vital for the Anticancer Activity of Withaferin A
Brane, A. C., Sutko, M., & Tollefsbol, T. O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031210 · Cited by 5
Secondary Metabolites from Croton Species and Their Biological Activity on Cell Cycle Regulators
Alamillo-Vásquez, J. A., Pérez-Torres, C.-A., Ibarra‐Laclette, E., Ramón-Farías, F., Nicasio-Torres, P., & Alatorre‐Cobos, F. (2025) · Metabolites · doi:10.3390/metabo15040216 · Cited by 5
Arndt, S., Unger, P., Ivanova, I., Bäumler, W., Drexler, K., Berneburg, M., & Karrer, S. (2025) · Pharmaceuticals · doi:10.3390/ph18060907 · Cited by 5
Hippo effector, Yorkie, is a tumor suppressor in select Drosophila squamous epithelia
Bhattacharya, R., Kumari, J., Banerjee, S., Tripathi, J., Parihar, S. S., Mohan, N., & Sinha, P. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319666121 · Cited by 5
Acute Three‐Dimensional Hypoxia Regulates Angiogenesis
Ntekoumes, D., Song, J., Liu, H., Amelung, C. D., Guan, Y., & Gerecht, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403860 · Cited by 7
Enhanced expression of p21 promotes sensitivity of melanoma cells towards targeted therapies
Fröhlich, L. M., Makino, E., Sinnberg, T. W., & Schittek, B. (2022) · Experimental Dermatology · doi:10.1111/exd.14585 · Cited by 5
Fan, Y.-C., Meng, Z.-Y., Zhang, C., Wei, D.-W., Wei, W.-S., Xie, X.-D., Huang, M.-L., & Jiang, L. (2023) · PeerJ · doi:10.7717/peerj.15700 · Cited by 5
A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
Pereira, M., & Vale, N. (2023) · International Journal of Translational Medicine · doi:10.3390/ijtm3040032 · Cited by 5
Metadata
- Authors
- Shamloo, B., & Usluer, S.
- Affiliations
- University of Utah (US)
- Medical University of Graz (AT)
- Corresponding author
- Shamloo, Bahar
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-08-14
- Volume
- 11
- Issue
- 8
- Pages
- 1178
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC6721478
- OpenAlex
- W2968190332
- Cited by
- 336
- References
- 175
- Citations by year
- 2026: 18 · 2025: 47 · 2024: 63 · 2023: 65 · 2022: 52 · 2021: 56 · 2020: 31 · 2019: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p21, cell cycle inhibitors, p53, tumor suppression, phenotypic plasticity, oncogenic function, anti-apoptotic effects, subcellular localization, genome editing, cancer therapy, drug sensitivity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review